23. Segment Information

Audited information

Clariant has grouped its activities into four (reportable segments): Care Chemicals (BU ICS), Catalysis (BU ), Natural Resources (BU Oil & Mining Services, BU Functional Minerals) and Plastics & Coatings (BU , BU , BU ).

Intersegment transactions are entered into under the normal circumstances and terms and conditions that would also be available to unrelated third parties.

Segment assets consist of property, plant and equipment, goodwill, intangible assets, inventories, receivables and investments in associates. They exclude deferred tax assets, financial assets and operating cash. Segment liabilities comprise trade payables. They exclude items such as tax liabilities, provisions, pension liabilities and corporate borrowings. Capital expenditure comprises additions to property, plant and equipment and intangibles.

Segments

in CHF m

 

Care Chemicals

 

Catalysis

 

Natural Resources

 

Plastics & Coatings

 

Corporate

 

Total Group

 

 

2017

 

2016

 

2017

 

2016

 

2017

 

2016

 

2017

 

2016

 

2017

 

2016

 

2017

 

2016

1

EBITDA is earning before interest, tax, depreciation and amortization.

Segment sales

 

1 589

 

1 473

 

767

 

673

 

1 364

 

1 190

 

2 709

 

2 547

 

 

 

6 429

 

5 883

Sales to other segments

 

–14

 

–8

 

 

 

–7

 

–6

 

–31

 

–22

 

 

 

–52

 

–36

Total sales

 

1 575

 

1 465

 

767

 

673

 

1 357

 

1 184

 

2 678

 

2 525

 

 

 

6 377

 

5 847

Operating expenses

 

–1 375

 

–1 254

 

–639

 

–571

 

–1 223

 

–1 039

 

–2 381

 

–2 256

 

–263

 

–215

 

–5 881

 

–5 335

Thereof:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income from associates and joint ventures

 

10

 

9

 

11

 

13

 

5

 

12

 

30

 

34

 

47

 

17

 

103

 

85

Gain/loss from disposals not qualifying as discontinued operations

 

 

 

 

 

 

 

1

 

–2

 

2

 

–1

 

3

 

–3

Restructuring, impairment and transaction-related costs

 

–30

 

–10

 

–7

 

–11

 

–14

 

–14

 

–14

 

–18

 

–115

 

–54

 

–180

 

–107

Operating income

 

200

 

211

 

128

 

102

 

134

 

145

 

297

 

269

 

–263

 

–215

 

496

 

512

Net financial expenses and taxes

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

–194

 

–249

Net income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

302

 

263

Segment assets

 

1 160

 

1 096

 

1 780

 

1 673

 

1 298

 

1 296

 

1 798

 

1 693

 

 

 

 

 

6 036

 

5 758

Segment liabilities

 

–244

 

–206

 

–90

 

–95

 

–150

 

–135

 

–273

 

–249

 

 

 

 

 

–757

 

–685

Net operating assets

 

916

 

890

 

1 690

 

1 578

 

1 148

 

1 161

 

1 525

 

1 444

 

 

 

5 279

 

5 073

Net assets held for sale

 

10

 

 

5

 

5

 

4

 

 

2

 

2

 

1

 

 

22

 

7

Corporate assets without cash

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1 416

 

1 275

 

1 416

 

1 275

Corporate liabilities without financial liabilities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

–2 239

 

–2 269

 

–2 239

 

–2 269

Net debt see

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

–1 539

 

–1 540

 

–1 539

 

–1 540

Total net assets

 

926

 

890

 

1 695

 

1 583

 

1 152

 

1 161

 

1 527

 

1 446

 

–2 361

 

–2 534

 

2 939

 

2 546

Thereof:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Investments in PPE and intangibles for the period

 

61

 

79

 

36

 

87

 

49

 

40

 

86

 

82

 

47

 

48

 

279

 

336

Investments in associates and joint ventures at the end of the period

 

64

 

56

 

121

 

193

 

9

 

14

 

154

 

148

 

160

 

105

 

508

 

516

Reconciliation of key figures

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating income

 

200

 

211

 

128

 

102

 

134

 

145

 

297

 

269

 

–263

 

–215

 

496

 

512

Add: systematic depreciation of PPE

 

54

 

49

 

41

 

30

 

36

 

27

 

68

 

69

 

32

 

35

 

231

 

210

Add: impairment

 

 

 

1

 

5

 

1

 

 

12

 

3

 

2

 

 

16

 

8

Add: amortization of intangible assets

 

6

 

6

 

22

 

17

 

23

 

14

 

10

 

10

 

9

 

8

 

70

 

55

EBITDA1

 

260

 

266

 

192

 

154

 

194

 

186

 

387

 

351

 

–220

 

–172

 

813

 

785

Add: restructuring, impairment and transaction-related costs

 

30

 

10

 

7

 

11

 

14

 

14

 

14

 

18

 

115

 

54

 

180

 

107

Less: impairment

 

 

 

–1

 

–5

 

–1

 

 

–12

 

–3

 

–2

 

 

–16

 

–8

Less: gain/loss from disposals not qualifying as discontinued operations

 

 

 

 

 

 

 

–1

 

2

 

–2

 

1

 

–3

 

3

Adjusted EBITDA

 

290

 

276

 

198

 

160

 

207

 

200

 

388

 

368

 

–109

 

–117

 

974

 

887

Operating income

 

200

 

211

 

128

 

102

 

134

 

145

 

297

 

269

 

–263

 

–215

 

496

 

512

Add: restructuring, impairment and transaction-related costs

 

30

 

10

 

7

 

11

 

14

 

14

 

14

 

18

 

115

 

54

 

180

 

107

Less: gain/loss from disposals not qualifying as discontinued operations

 

 

 

 

 

 

 

–1

 

2

 

–2

 

1

 

–3

 

3

Adjusted operating income

 

230

 

221

 

135

 

113

 

148

 

159

 

310

 

289

 

-150

 

-160

 

673

 

622

Reconciliation of segment assets to total assets

in CHF m

 

31.12.2017

 

31.12.2016

Segment assets

 

6 036

 

5 758

Segment assets reported as assets held for sale

 

21

 

7

Corporate assets reported as assets held for sale

 

1

 

Corporate assets without cash

 

1 416

 

1 275

Cash

 

701

 

1 043

Short-term deposits

 

47

 

277

Financial instruments with positive fair values

 

7

 

5

Total assets

 

8 229

 

8 365

in CHF m

 

Sales1

 

Non-current assets2

 

 

2017

 

2016

 

31.12.2017

 

31.12.2016

1

Allocated by region of third-party sale’s destination.

2

Non-current assets exclude deferred tax assets and pension plan assets.

EMEA

 

2 674

 

2 423

 

2 438

 

2 368

of which Germany

 

757

 

672

 

1 458

 

1 470

of which Switzerland

 

34

 

36

 

585

 

512

of which MEA

 

480

 

419

 

62

 

74

North America

 

1 241

 

1 120

 

1 234

 

1 321

of which USA

 

1 143

 

1 030

 

1 213

 

1 299

Latin America

 

830

 

846

 

248

 

253

of which Brazil

 

355

 

327

 

146

 

156

Asia/Pacific

 

1 632

 

1 458

 

663

 

550

of which China

 

534

 

474

 

182

 

185

of which India

 

209

 

182

 

217

 

103

Total

 

6 377

 

5 847

 

4 583

 

4 492

All of the Group’s segments generate their revenues to the largest extent from the sale of products. These come in such a great variety that a meaningful grouping below the segment information is not possible.

For a description of the Business Units see .

Business Area

In 2013 Clariant adjusted its reporting segments and grouped its businesses with similar end-user markets and growth drivers into four distinct Business Areas: Care Chemicals, Catalysis, Natural Resources, and Plastics & Coatings. VIEW ENTIRE GLOSSARY

Catalyst

A substance that lowers the activation energy, thereby increasing the rate of a chemical reaction without being consumed by the reaction itself (Clariant Business Unit Catalysts). VIEW ENTIRE GLOSSARY

Additive

A substance added to products in small quantities to achieve certain properties or to improve a product (Clariant Business Unit Additives). VIEW ENTIRE GLOSSARY

Masterbatches

These are plastic additives in the form of granules with dyestuffs or other additives used to dye or alter the properties of natural plastic. VIEW ENTIRE GLOSSARY

Pigment

Pigments are substances used for coloring; they are used in a technical manner, for example in the manufacture of dyes, varnishes, and plastics. VIEW ENTIRE GLOSSARY

FURTHER READING